Nephron Pharmaceuticals Announces Leadership Transition
Nephron LLC and its subsidiaries (“Nephron” or the “Company”) today announced the departure of Lou Kennedy from her role as Chief Executive Officer. Haywood Miller has been appointed Interim Chief Executive Officer, effective immediately.
